These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 3958744)

  • 21. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
    Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
    Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
    [No Abstract]   [Full Text] [Related]  

  • 22. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of HLA-B8, DRw3, and anti-acetylcholine receptor antibodies in myasthenia gravis.
    Naeim F; Keesey JC; Herrmann C; Lindstrom J; Zeller E; Walford RL
    Tissue Antigens; 1978 Nov; 12(5):381-6. PubMed ID: 85353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gm allotypes in myasthenia gravis.
    Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Ota K; Fujita T; Tsuji K
    Lancet; 1980 Mar; 1(8170):677-80. PubMed ID: 6103092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis.
    Dawkins RL; Christiansen FT; Garlepp MJ
    Ann N Y Acad Sci; 1981; 377():372-84. PubMed ID: 6951482
    [No Abstract]   [Full Text] [Related]  

  • 27. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MI; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Apr; 286(6375):1442-3. PubMed ID: 6404496
    [No Abstract]   [Full Text] [Related]  

  • 28. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy.
    Ahlsten G; Lefvert AK; Osterman PO; Stålberg E; Säfwenberg J
    J Child Neurol; 1992 Jul; 7(3):264-9. PubMed ID: 1634748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of HLA antigens with myasthenia gravis in Chinese on Taiwan.
    Chiu HC; Hsieh RP; Hsieh KH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Feb; 23(1):12-8. PubMed ID: 2394179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
    Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
    Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myasthenia.
    Heidenreich F; Vincent A; Newsom-Davis J
    Autoimmunity; 1988; 2(1):31-7. PubMed ID: 3155153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of HLA in clinical courses of myasthenia gravis.
    Hayashi M; Kida K; Yamada I; Matsuda H; Sonoda S; Inoue H; Shiga S
    J Neuroimmunol; 1988 May; 18(2):171-9. PubMed ID: 3356802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
    Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
    BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
    Savage-Marengo T; Harrison R; Lunt GG; Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired myasthenia gravis in childhood.
    Evoli A
    Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.